2006
DOI: 10.1086/506950
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of the Triggering Receptor Expressed on Myeloid Cells–1 Pathway during Pneumonia in Rats

Abstract: The modulation of the TREM-1 pathway by the use of such synthetic peptides as LP17 appears beneficial during P. aeruginosa pneumonia in rats in attenuating lung and systemic inflammatory responses.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
75
0
1

Year Published

2010
2010
2017
2017

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 80 publications
(80 citation statements)
references
References 25 publications
(41 reference statements)
4
75
0
1
Order By: Relevance
“…Furthermore, in accordance with our findings in antibody experiments, Pilrb Ϫ/Ϫ mice were more resistant to infection than were WT mice and exhibited decreased bacterial burden and greater survival. A similar protective phenotype was observed during Pseudomonas aeruginosa induced-pneumonia in rats wherein blocking TREM-1 by using LP17 peptide appeared to be beneficial (16). In a lipopolysaccharide (LPS)-induced septic shock model, 100% mortality was observed in mice injected with an agonist TREM-1 antibody.…”
Section: Discussionsupporting
confidence: 52%
“…Furthermore, in accordance with our findings in antibody experiments, Pilrb Ϫ/Ϫ mice were more resistant to infection than were WT mice and exhibited decreased bacterial burden and greater survival. A similar protective phenotype was observed during Pseudomonas aeruginosa induced-pneumonia in rats wherein blocking TREM-1 by using LP17 peptide appeared to be beneficial (16). In a lipopolysaccharide (LPS)-induced septic shock model, 100% mortality was observed in mice injected with an agonist TREM-1 antibody.…”
Section: Discussionsupporting
confidence: 52%
“…Gibot and colleagues examined the role of TREM-1 in bacterial pneumonia using a different approach (17). Their study involved instillation of a TREM-1-blocking peptide, LP-17, into the rat trachea following pneumonia challenge.…”
Section: Discussionmentioning
confidence: 99%
“…Accordingly, numerous clinical examples of impaired neutrophil function are linked to increased rates of infection and death, including chronic granulomatous disease (CGD), neutropenic fever, and lymphocyte adhesion deficiency. However, animal studies indicate that effective bacterial clearance can be achieved in the setting of decreased inflammation (16,17). In the case of TREM-1, blockade of TREM-1 has been achieved by administering soluble forms of TREM-1, small molecule blocker (LP-17), or RNA silencing (10,18,19).…”
Section: Introductionmentioning
confidence: 99%
“…In fine, LP17 treatment improved survival. 36 In Southeast Asia and northern Australia the Gram-negative bacillus Burkholderia pseudomallei is an important cause of community-acquired sepsis. More than half of these cases of melioidosis, as this severe infection is named, habitually present with pneumonia, frequently associated with bacterial dissemination to distant sites.…”
Section: Trem-1 Structure and Functionmentioning
confidence: 99%